Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Free-flap head and neck reconstruction and quality of life: a 2-year prospective study.
Bozec A, Poissonnet G, Chamorey E, Casanova C, Vallicioni J, Demard F, Mahdyoun P, Peyrade F, Follana P, Bensadoun RJ, Benezery K, Thariat J, Marcy PY, Sudaka A, Dassonville O. Bozec A, et al. Among authors: bensadoun rj. Laryngoscope. 2008 May;118(5):874-80. doi: 10.1097/MLG.0b013e3181644abd. Laryngoscope. 2008. PMID: 18300703
[2003 Update of Standards, Options and Recommendations for management of patients with salivary gland malignant tumors (excluding lymphoma, sarcoma and melanoma) (summary report)].
Bensadoun RJ, Allavena C, Chauvel P, Dassonville O, Demard F, Dieu-Bosquet L, Lacau St Guily J, Ettore F, Gory-Delabaere G, Marcy PY, Reyt E; Fédération Nationale des Centres de Lutte Contre le Cancer; Standards Options & Recommandations; Ligue contre le Cancer Comites 101; Fédération Hospitalières de France; Fédération Française de Cancerologie; Fédération Nationale de Cancerologie des CHRU. Bensadoun RJ, et al. Bull Cancer. 2003 Jul;90(7):629-42. Bull Cancer. 2003. PMID: 12957805 Free article. French.
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ, Bénézery K, Dassonville O, Magné N, Poissonnet G, Ramaïoli A, Lemanski C, Bourdin S, Tortochaux J, Peyrade F, Marcy PY, Chamorey E, Vallicioni J, Seng H, Alzieu C, Géry B, Chauvel P, Schneider M, Santini J, Demard F, Calais G. Bensadoun RJ, et al. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):983-94. doi: 10.1016/j.ijrobp.2005.09.041. Epub 2006 Jan 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16376489 Clinical Trial.
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, Maingon P, Giraud P, Bourhis J, Marchesi V, Mège A, Peiffert D. Graff P, et al. Among authors: bensadoun rj. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1309-17. doi: 10.1016/j.ijrobp.2006.11.012. Epub 2007 Feb 7. Int J Radiat Oncol Biol Phys. 2007. PMID: 17289292
[Upper aerodigestive tract carcinoma: therapeutic management].
Poissonnet G, Benezery K, Peyrade F, Bozec A, Bensadoun RJ, Marcy PY, Santini J, Dassonville O. Poissonnet G, et al. Among authors: bensadoun rj. Presse Med. 2007 Nov;36(11 Pt 2):1634-42. doi: 10.1016/j.lpm.2007.03.036. Epub 2007 Apr 23. Presse Med. 2007. PMID: 17451911 Review. French.
Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Racadot S, Mercier M, Dussart S, Dessard-Diana B, Bensadoun RJ, Martin M, Malaurie E, Favrel V, Housset M, Durdux C, Journel C, Calais G, Huet J, Pillet G, Hennequin C, Haddad E, Diana C, Blaska-Jaulerry B, Henry-Amar M, Géhanno P, Baillet F, Mazeron JJ. Racadot S, et al. Among authors: bensadoun rj. Radiother Oncol. 2008 May;87(2):164-72. doi: 10.1016/j.radonc.2007.12.021. Epub 2008 Jan 25. Radiother Oncol. 2008. PMID: 18222010 Clinical Trial.
Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
Ortholan C, Chamorey E, Benezery K, Thariat J, Dassonville O, Poissonnet G, Bozec A, Follana P, Peyrade F, Sudaka A, Gerard JP, Bensadoun RJ. Ortholan C, et al. Among authors: bensadoun rj. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):178-86. doi: 10.1016/j.ijrobp.2008.03.068. Epub 2008 Jun 17. Int J Radiat Oncol Biol Phys. 2009. PMID: 18565687 Clinical Trial.
190 results